Form 4: GoodRx Holdings Executive Sells 79,000 Shares of Class A Common Stock

Sentiment:

SEC Form 4 Filing


Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc., sold 79,000 shares of Class A Common Stock on August 12, 2024, at a weighted average price of $6.7674.

Summary

  • On August 12, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., sold 79,000 shares of Class A Common Stock.
  • The sale was executed at a weighted average price of $6.7674 per share.
  • The prices for individual transactions ranged from $6.705 to $6.865.
  • Following the transaction, Nabiey directly owns 64,633 shares of GoodRx Holdings, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an insider stock sale. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by investors.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company executives. It's important for investors to monitor such filings to gain insights into management's perspective on the company's stock.

Key Dates

DateDescription
08/12/2024Date of transaction: Romin Nabiey sold 79,000 shares of Class A Common Stock.
08/14/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.